Characterisation of high throughput screening outputs for small molecule degrader discovery.
Saved in:
| Title: | Characterisation of high throughput screening outputs for small molecule degrader discovery. |
|---|---|
| Authors: | Bell LE; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-BioCenter 1, 1030 Vienna, Austria; Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, 1030, Vienna, Austria., Bardelle C; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK., Packer MJ; TDE, Oncology, R&D, AstraZeneca, Cambridge, UK., Kastl J; Assay.Works GmbH, Am Biopark 11, Regensburg, Germany., Holdgate GA; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK. Electronic address: geoff.holdgate@astrazeneca.com., Davies G; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK. |
| Source: | SLAS discovery : advancing life sciences R & D [SLAS Discov] 2024 Jul; Vol. 29 (5), pp. 100162. Date of Electronic Publication: 2024 May 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101697563 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2472-5560 (Electronic) Linking ISSN: 24725552 NLM ISO Abbreviation: SLAS Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
